2017
DOI: 10.1515/romneu-2017-0062
|View full text |Cite
|
Sign up to set email alerts
|

The many faces of primary cauda equina myxopapillary ependymoma: clinicoradiological manifestations of two cases and review of the literature

Abstract: Abstract:Introduction: Myxopapillary ependymoma (MPE) is a benign and slow growing tumor that originates exclusively from the conus medullaris and cauda equina nervous tissue. It occurs more commonly in young patients. In addition, clinical presentations are non-specific and may mimic benign conditions. Magnetic resonance imaging (MRI) is the imaging modality of choice for evaluating this tumor. We hereby report on two young patients with long-lasting non-specific symptoms, which were clinically attributed to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…According to the 2016 classification by the World Health Organization (WHO), an ependymoma is traditionally classified into three histopathological subtypes, including WHO grade I (myxopapillary ependymoma, subependymoma), WHO grade II (ependymoma), WHO grade III (anaplastic ependymoma), and WHO grade II or III (RELA fusion-positive) (Table 1) [24]. A myxopapillary ependymoma, a slow-growing low-grade tumor, accounts for approximately 10% of ependymomas [25]. A myxopapillary ependymoma is a rare tumor located in the conus medullaris, cauda equinea, and filum terminale of the spinal cord [26].…”
Section: Histopathological Classification Of Ependymomamentioning
confidence: 99%
“…According to the 2016 classification by the World Health Organization (WHO), an ependymoma is traditionally classified into three histopathological subtypes, including WHO grade I (myxopapillary ependymoma, subependymoma), WHO grade II (ependymoma), WHO grade III (anaplastic ependymoma), and WHO grade II or III (RELA fusion-positive) (Table 1) [24]. A myxopapillary ependymoma, a slow-growing low-grade tumor, accounts for approximately 10% of ependymomas [25]. A myxopapillary ependymoma is a rare tumor located in the conus medullaris, cauda equinea, and filum terminale of the spinal cord [26].…”
Section: Histopathological Classification Of Ependymomamentioning
confidence: 99%